-
Abstract Number: 359
Impact of Hospital Admissions on Adherence to Allopurinol Therapy After Discharge
-
Abstract Number: 360
Colchicine Prophylaxis of Gout Flares When Commencing Allopurinol Is Very Cost Effective: A Health Economic Analysis
-
Abstract Number: 361
Frequency of Allopurinol Dose Reduction in Hospitalized Patients with Gout Flares
-
Abstract Number: 362
Methods to Efficiently Recruit Minority Patients with Gout for Clinic-Based Registries
-
Abstract Number: 363
Efficacy and Outcomes of Telephone-Based Management Program in Patients with Gout
-
Abstract Number: 364
Calcium Pyrophosphate Crystal Arthritis During Hospitalizations: A Prospective, Crystal-Proven Case Series
-
Abstract Number: 365
Classifying Pseudogout Using Machine Learning Approaches with Electronic Health Record Data
-
Abstract Number: 366
Serum Uric Acid Level and Subclinical Coronary Atherosclerosis in Asymptomatic Individuals: An Observational Cohort Study
-
Abstract Number: 367
Understanding the Mystery of Sarcoidosis: An Academic Rheumatology Center Experience
-
Abstract Number: 368
Practice Patterns in Bone Health and Vitamin D Management in Sarcoidosis: A Survey of Physicians Who Manage Sarcoidosis
-
Abstract Number: 369
Methotrexate and Interstitial Lung Disease in Patients with Inflammatory Articular Disease: A Systematic Review
-
Abstract Number: 370
Use of Serum Lung Injury Biomarkers for Predicting the Severity of Interstitial Lung Disease in Patients with Connective Tissue Disease Associated Interstitial Lung Disease and Interstitial Pneumonia with Autoimmune Features
-
Abstract Number: 371
Role of Alternative Immunosuppressant Therapy in Management of Cardiac Sarcoidosis
-
Abstract Number: 372
Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean Experience
-
Abstract Number: 373
Prognostic Factors and Long-term Outcomes in Cardiac Sarcoidosis
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 198
- Next Page »